I expect the perceived timing/"opportunity" cost scenario is what is keeping this in this range. Value on the other hand just keeps building and building here. What an incredibly well run exceptional company EMV is!
- Forums
- ASX - By Stock
- EMV
- Ann: EMVision Releases its FY25 Half Yearly Report
EMV
emvision medical devices ltd
Add to My Watchlist
0.28%
!
$1.80

Ann: EMVision Releases its FY25 Half Yearly Report, page-22
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.80 |
Change
0.005(0.28%) |
Mkt cap ! $153.9M |
Open | High | Low | Value | Volume |
$1.78 | $1.83 | $1.76 | $62.13K | 34.67K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 428 | $1.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.82 | 10740 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 428 | 1.800 |
1 | 2000 | 1.785 |
3 | 6594 | 1.780 |
1 | 5000 | 1.770 |
1 | 5901 | 1.760 |
Price($) | Vol. | No. |
---|---|---|
1.820 | 10740 | 2 |
1.830 | 4500 | 1 |
1.845 | 2000 | 1 |
1.850 | 5000 | 1 |
1.860 | 1136 | 1 |
Last trade - 15.33pm 18/06/2025 (20 minute delay) ? |
Featured News
EMV (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online